Related Experiment Video
Updated: May 15, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Smoking and 2-month culture conversion during anti-tuberculosis treatment
E L Maciel1, A P Brioschi, R L Peres
1Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil. ethel.maciel@gmail.com
Smoking significantly delays sputum culture conversion in tuberculosis patients. This finding highlights the need for smoking cessation support to improve treatment outcomes and tuberculosis control.
Area of Science:
- Pulmonology
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) treatment success relies on timely sputum culture conversion to negative.
- Delayed culture conversion can indicate treatment failure and ongoing transmission.
- Smoking is a prevalent risk factor in many populations with high TB burden.
Purpose of the Study:
- To identify risk factors associated with delayed sputum culture conversion during anti-tuberculosis therapy.
- To specifically evaluate the impact of smoking on achieving negative sputum cultures.
Main Methods:
- A nested case-control study was conducted within an anti-tuberculosis treatment trial in Brazil.
- Adults with culture-confirmed pulmonary tuberculosis were analyzed.
- Delayed culture conversion was defined as remaining culture-positive after 2 months of treatment.
Main Results:
- Smokers demonstrated a three-fold increased odds of remaining culture-positive at 2 months compared to non-smokers (P = 0.007).
- Individuals smoking >20 cigarettes daily, including ex-smokers, had double the odds of delayed culture conversion (P = 0.045).
Conclusions:
- Cigarette smoking is a significant adverse factor affecting sputum culture conversion rates in tuberculosis patients.
- Integrating smoking cessation interventions into TB control programs is crucial for improving treatment outcomes.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
